Which of the following laboratory findings is known as ‘biochemical marker of pre-eclampsia’?
**Core Concept:** Pre-eclampsia is a pregnancy-specific disorder characterized by hypertension and proteinuria after the 20th week of gestation. It affects the mother and can lead to severe complications for both the mother and the fetus. Biochemical markers play a crucial role in early detection, monitoring, and assessing disease severity.
**Why the Correct Answer is Right:** The correct answer, **Plasminogen Activator Inhibitor-1 (PAI-1)**, is a biochemical marker associated with pre-eclampsia. PAI-1 is an inhibitor of plasminogen activator, which is responsible for breaking down the uterine blood vessels' fibrin clots. In pre-eclampsia, increased levels of PAI-1 hinder the breakdown of these clots, leading to impaired uteroplacental perfusion and organ damage.
**Why Each Wrong Option is Incorrect:**
A. **Platelet Activating Factor (PAF):** PAF is involved in inflammation and allergic reactions, not directly related to pre-eclampsia.
B. **C-peptide:** C-peptide is a byproduct of insulin secretion and does not serve as a marker for pre-eclampsia.
C. **Urinary Estriol:** This hormone is a product of fetal adrenal glands and is not directly associated with pre-eclampsia pathogenesis.
D. **Fibrinogen:** While fibrinogen is a coagulation factor, its increased levels are more indicative of endothelial dysfunction rather than specifically pre-eclampsia.
**Clinical Pearl:** Early detection and monitoring of biochemical markers like PAI-1 can help identify women at risk for developing pre-eclampsia. Identifying these markers may lead to timely interventions, improved maternal and fetal outcomes, and reduced maternal morbidity and mortality.